Buy or sell PIQUR Therapeutics stock pre IPO via an EquityZen fund
PIQUR Therapeutics Stock
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
About PIQUR Therapeutics Stock
PIQUR is a Swiss clinical-stage pharmaceutical company incorporated in August 2011 as a spin-off of the University of Basel, focusing on the discovery and development of innovative anti-cancer drugs based on lipid kinase (PI3K) and mTOR inhibition. PIQUR’s pipeline originates from one of the most promising research areas in oncology. Both PI3K and mTOR are clinically validated drug targets in oncology. PIQUR has a secured patent scope protecting many chemical compounds.
Chief Scientific Officer
Head BD & Communications
Head Drug Discovery
Head of Preclinical Safety & Toxicology